Siemens Healthineers raises $5.2B with IPO

Siemens’ healthcare division, Siemens Healthineers, began trading on Germany’s stock exchange Friday, raising $5.2 billion (4.2 billion euros) by selling 15 percent of the company. Shares of were issued at 28 euros each but opened at 29.10 euros each.

The initial public offering (IPO) has been in the works for months, with numerous reports indicating it could occur by the end of March. This is widely viewed as one of the biggest public equity offerings in the history of Germany’s stock market.

Technical difficulties with Deutsche Boerse’s trading platform delayed the launch by more than an hour. Bernd Montag, Siemens Healthineers CEO, said in an interview with CNBC that it ultimately “didn’t make a big difference and we are happy that we made it anyway.”

The IPO is designed to help Siemens Healthineers fund future acquisitions and investments. There are also financial benefits to having stock to offer in future business dealings as opposed to cash.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

These risks appear to be present regardless of a person's age or health at the time of infection.